OpenLobby.EU
Explore

Amendment of Regulation (EU) 2019/1021 on persistent organic pollutants as regards the listing of PFOA in Annex I

Environment

Links

Public consultation

ID: 12057

Lobbying Activity

6 responses

European Environmental Bureau demands stricter EU PFOA limits

European Environmental Bureau, 5 Dec 2019

The organization requests lowering the unintentional trace contaminant level from 25 ppb to 2 ppb and rejecting all proposed derogations for PFOA use in photographic films, textiles, medical devices, PTFE/PVDF manufacturing, firefighting foams, and pharmaceutical products. They argue these exemptions are unnecessary because alternatives exist and that the proposed limits ignore modern analytical capabilities and PFOA's extreme toxicity.
This would strengthen public health protections by reducing exposure to toxic PFOA chemicals.
Industry loses exemptions allowing continued PFOA use despite availability of safer alternatives.

Consultation response

Wirtschaftskammer Österreich, 5 Dec 2019

Die Ausnahme für Plasma Nano Coatings sollte unter Art. 5 der POP VO analog zur REACH-Beschränkung (Anh. XVII, Eintrag 68, Abs. 3b (iii) aufgenommen werden. Derzeit gibt für es diverse Anwendungsfälle noch keine Alternative zum Plasma Nano Coating. So kommen beispielsweise bei Öl/Wasser, Gas, Blut…

MedTech Europe urges longer PFOA transition for medical devices

MedTech Europe, 5 Dec 2019

MedTech Europe requests a time-limited exemption until 2030 for medical devices. This would avoid market disruption and allow for a properly enforceable substitution.
This allows companies to avoid immediate product bans and high compliance costs.
Future patients lose access to life-saving technology if essential devices are discontinued.

COCIR warns PFOA restrictions threaten medical device availability

European Coordination Committee of the Radiological, Electromedical and healthcare IT Industry, 3 Dec 2019

COCIR requests a minimum five-year exemption for medical imaging and radiotherapy equipment. Currently proposed timelines are technically impossible for complex global supply chains.
An extended deadline avoids high redesign costs and preserves existing product lines.
European patients risk losing access to critical diagnostic tools and cancer treatment systems.

Consultation response

Confederation of the German Textile and Fashion Industry, 5 Dec 2019

The Confederation of the German Textile and Fashion Industry is the umbrella association of the German textile and fashion industry. It represents the industry at national and international level in matters of economic and social policy. Its members are 11 associations of the textile and fashion…

Consultation response

SEMI Europe, 4 Dec 2019

SEMI welcomes the opportunity to provide comments into the consultation on legislation to add PFOA and related substances as a restriction under the EU POPs regulation. Please find attached our feedback.